Developer docs
API playgroundTry for free, no card

Search company profiles

KPL

Full company profile

uuid003sm8m

Namestring
KPL
Legal namestring
LGC Clinical Diagnostics, Inc.
Websiteurl
kpl.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

KPL (Kirkegaard & Perry Laboratories) operates as an immunoassay reagent product line within SeraCare, the clinical diagnostics brand of LGC Clinical Diagnostics, Inc., a Massachusetts-incorporated subsidiary of UK-based LGC Group. The KPL line supplies ready-to-use antibodies, conjugates, and immunoassay reagent kits to in vitro diagnostic (IVD) assay developers, clinical laboratories, and research institutions that need standardized biological materials to validate and accelerate diagnostic test development. KPL's commercial context is the broader SeraCare portfolio, which spans Seraseq next-generation sequencing (NGS) reference standards, ACCURUN molecular and serology quality controls, AccuVert seroconversion panels, AccuSet performance panels, AccuTrak qualification panels, AccuSpan linearity panels, AccuPlex recombinant virus reference materials, and Virusys viral disease antibodies and controls.

The underlying technology is fundamentally biological rather than digital: characterized patient-derived specimens (e.g., raw undiluted plasma, serially drawn seroconversion samples), recombinant virus constructs for unculturable or high-containment pathogens, formalin-fixed paraffin-embedded (FFPE) materials, and affinity-purified antibody/conjugate reagents, each accompanied by batch-level certificates of analysis and comparative test data sheets across leading IVD platforms. Manufacturing is anchored at three US sites — Milford, MA (headquarters), Gaithersburg, MD, and Cumberland Foreside, ME — supporting both catalog production and custom OEM/bulk processing work. Distribution is direct via the seracare.com e-commerce storefront (account-gated pricing) plus account-based OEM sales to leading diagnostic assay developers, with global shipping across North America, Western Europe, and East Asia. The business model is predominantly one-time catalog sales of reference materials and immunoassay reagents, supplemented by custom services (custom NGS libraries, EQA proficiency panels, prospective collections, bulk processed plasma and serum) priced as professional services engagements.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMilford, United States
HQ citystring
Milford
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
immunoassay reagents, antibodies conjugates, IVD assay development, diagnostic quality control, research antibodies
Industry2 codes
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Diagnostic Reagents
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1KPL Immunoassay Products
TypeOne Time License
Description

Sale of antibodies, conjugates, and immunoassay reagents/kits to IVD assay developers and clinical laboratories for research and diagnostic assay development purposes

seracare.com
2Reference Materials & Controls
TypeOne Time License
Description

Sale of NGS reference standards, seroconversion panels, performance panels, qualification panels, and linearity panels to clinical laboratories and IVD manufacturers

seracare.com
3Custom Services
TypeProfessional Services
Description

Custom NGS solutions, molecular and serology controls and panels, EQA proficiency panels, antibodies and reagents, prospective collections, and bulk processed plasma and serum services for assay developers

seracare.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales
Pricing details1 tier
1KPL Antibodies & Conjugates
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products available in various sizes (e.g., 1 mL, 10 mL, 50 mL, bulk). Pricing requires account login.

seracare.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1KPL
Description

KPL (Kirkegaard & Perry Laboratories) provides antibodies, conjugates, immunoassay reagents and kits for research and IVD assay development.

seracare.com
+7 more records
Core offering1 text field

KPL (Kirkegaard & Perry Laboratories) is a product line and sub-brand of SeraCare Life Sciences (LGC Clinical Diagnostics) that manufactures and sells ready-to-use antibodies, conjugates, and immunoassay reagent kits. These products are designed to accelerate research workflows and in vitro diagnostic (IVD) assay development for clinical laboratories, IVD manufacturers, and assay developers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

KPL (Kirkegaardgaard & Perry Laboratories) is a sub-brand of SeraCare Life Sciences offering two complementary product lines for immunoassay development: KPL Antibodies & Conjugates (providing antibodies and conjugate reagents) and KPL Immunoassay Reagents & Kits (providing assay reagents and kit solutions). These products are positioned within SeraCare's broader portfolio of quality control tools for clinical laboratories, including NGS reference materials, serology controls, and infectious disease assay tools. The KPL products serve as readily available reagents to accelerate research and IVD assay development, fitting into SeraCare's ecosystem alongside their Seraseq reference materials, ACCURUN controls, and AccuSpan/AccuVert/AccuTrak panel products.

Product and service2 records
1KPL Antibodies & Conjugates
CategoryImmunoassay Reagents
Description

A comprehensive line of ready-to-use antibodies and conjugates for immunoassay development, providing readily available reagents to accelerate research and IVD (in vitro diagnostic) assay development. Targeted at IVD assay developers, clinical laboratories, and research institutions developing immunoassays and diagnostic tests.

2KPL Immunoassay Reagents & Kits
CategoryImmunoassay Reagents
Description

A range of complete immunoassay reagent kits designed to support research and IVD assay development workflows with readily available materials, intended to accelerate development timelines for diagnostic assay developers.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Roche Diagnostics is a global IVD leader across molecular, immunoassay, and clinical chemistry. It represents both an overlapping reference material/QC capability and a key end-customer segment that purchases OEM reference standards for its own assay development.

TypeBroad incumbent
Description

Thermo Fisher offers a broad portfolio of diagnostic reference materials, immunoassay reagents, and clinical QC tools through its Specialty Diagnostics and Life Sciences Solutions segments. It overlaps with SeraCare/KPL across antibodies, controls, and NGS reference standards but at much larger scale and broader scope.

TypeDirect peer
Description

ZeptoMetrix (part of Antylia Scientific) specializes in infectious disease reference materials, seroconversion panels, and viral antigens — directly overlapping with SeraCare's AccuVert, AccuSet, and Virusys product lines for IVD assay developers.

4SeraCare Life Sciences (parent brand)
TypeOthers
Description

SeraCare is the umbrella commercial brand under which KPL operates; included as a peer to clarify the parent-brand relationship rather than as a true external competitor (it is the same legal entity, LGC Clinical Diagnostics, Inc.).

TypeEmerging player
Description

ATCC provides biological reference materials, cell lines, and microbial standards used in assay development and QC. It overlaps with SeraCare's disease state specimens and recombinant virus materials for select IVD and research applications.

TypeDirect peer
Description

Bio-Rad is one of the largest manufacturers of IVD quality controls, reference materials, and specialty diagnostics reagents. It directly competes with SeraCare/KPL across molecular QC, serology controls, and immunoassay reagents, serving the same clinical lab and IVD developer customers.

TypeDirect peer
Description

Streck develops clinical lab quality controls, stabilization products, and reference materials for hematology, molecular, and infectious disease testing. It competes head-to-head with SeraCare's ACCURUN and panel products in clinical laboratory QC workflows.

TypeDirect peer
Description

Surmodics' Diagnostics division provides IVD reagents, antigens, antibodies, and OEM assay components to diagnostic manufacturers — a directly comparable offering to KPL's antibodies, conjugates, and immunoassay reagent kits.

9Maine Biotechnology Services
TypeEmerging player
Description

Maine Biotechnology Services specializes in custom antibody development and immunoassay reagents for IVD and research applications, overlapping with KPL's antibody and conjugate offerings for smaller-volume or custom OEM needs.

TypeBroad incumbent
Description

QuidelOrtho is a major IVD manufacturer with extensive immunoassay and infectious disease testing capabilities. It is a partial peer through its proprietary assay development but also a customer of reference materials like those SeraCare/KPL provides.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

KPL

Diagnostic Reagentskpl.com

What KPL does

KPL (Kirkegaard & Perry Laboratories) operates as an immunoassay reagent product line within SeraCare, the clinical diagnostics brand of LGC Clinical Diagnostics, Inc., a Massachusetts-incorporated subsidiary of UK-based LGC Group. The KPL line supplies ready-to-use antibodies, conjugates, and immunoassay reagent kits to in vitro diagnostic (IVD) assay developers, clinical laboratories, and research institutions that need standardized biological materials to validate and accelerate diagnostic test development. KPL's commercial context is the broader SeraCare portfolio, which spans Seraseq next-generation sequencing (NGS) reference standards, ACCURUN molecular and serology quality controls, AccuVert seroconversion panels, AccuSet performance panels, AccuTrak qualification panels, AccuSpan linearity panels, AccuPlex recombinant virus reference materials, and Virusys viral disease antibodies and controls.

The underlying technology is fundamentally biological rather than digital: characterized patient-derived specimens (e.g., raw undiluted plasma, serially drawn seroconversion samples), recombinant virus constructs for unculturable or high-containment pathogens, formalin-fixed paraffin-embedded (FFPE) materials, and affinity-purified antibody/conjugate reagents, each accompanied by batch-level certificates of analysis and comparative test data sheets across leading IVD platforms. Manufacturing is anchored at three US sites — Milford, MA (headquarters), Gaithersburg, MD, and Cumberland Foreside, ME — supporting both catalog production and custom OEM/bulk processing work. Distribution is direct via the seracare.com e-commerce storefront (account-gated pricing) plus account-based OEM sales to leading diagnostic assay developers, with global shipping across North America, Western Europe, and East Asia. The business model is predominantly one-time catalog sales of reference materials and immunoassay reagents, supplemented by custom services (custom NGS libraries, EQA proficiency panels, prospective collections, bulk processed plasma and serum) priced as professional services engagements.

KPL firmographics

Firmographics
Name
KPL
Legal name
LGC Clinical Diagnostics, Inc.
Website
https://kpl.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

KPL industry classification

Industry
Product category
Diagnostic Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAEAB
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • Immunoassay reagents
  • Antibodies conjugates
  • IVD assay development
  • Diagnostic quality control
  • Research antibodies

Where KPL is headquartered

Location

Headquarters

HQ city
Milford
HQ country
United States
HQ region
North America

Offices3 records

Markets served

KPL business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. KPL Immunoassay Products: Sale of antibodies, conjugates, and immunoassay reagents/kits to IVD assay developers and clinical laboratories for research and diagnostic assay development purposes
  2. Reference Materials & Controls: Sale of NGS reference standards, seroconversion panels, performance panels, qualification panels, and linearity panels to clinical laboratories and IVD manufacturers
  3. Custom Services: Custom NGS solutions, molecular and serology controls and panels, EQA proficiency panels, antibodies and reagents, prospective collections, and bulk processed plasma and serum services for assay developers

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goKPL Antibodies & Conjugates

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

KPL product offering

Product offering

Core offering

KPL (Kirkegaard & Perry Laboratories) is a product line and sub-brand of SeraCare Life Sciences (LGC Clinical Diagnostics) that manufactures and sells ready-to-use antibodies, conjugates, and immunoassay reagent kits. These products are designed to accelerate research workflows and in vitro diagnostic (IVD) assay development for clinical laboratories, IVD manufacturers, and assay developers.

Product overview

KPL (Kirkegaardgaard & Perry Laboratories) is a sub-brand of SeraCare Life Sciences offering two complementary product lines for immunoassay development: KPL Antibodies & Conjugates (providing antibodies and conjugate reagents) and KPL Immunoassay Reagents & Kits (providing assay reagents and kit solutions). These products are positioned within SeraCare's broader portfolio of quality control tools for clinical laboratories, including NGS reference materials, serology controls, and infectious disease assay tools. The KPL products serve as readily available reagents to accelerate research and IVD assay development, fitting into SeraCare's ecosystem alongside their Seraseq reference materials, ACCURUN controls, and AccuSpan/AccuVert/AccuTrak panel products.

Differentiator

Problem solved

Functional benefit

Brands

  • KPL: KPL (Kirkegaard & Perry Laboratories) provides antibodies, conjugates, immunoassay reagents and kits for research and IVD assay development.
  • Seraseq
  • ACCURUN
  • AccuVert
  • AccuSet
  • AccuTrak
  • AccuSpan
  • Virusys

Products and services

  • KPL Antibodies & Conjugates A comprehensive line of ready-to-use antibodies and conjugates for immunoassay development, providing readily available reagents to accelerate research and IVD (in vitro diagnostic) assay development. Targeted at IVD assay developers, clinical laboratories, and research institutions developing immunoassays and diagnostic tests.
  • KPL Immunoassay Reagents & Kits A range of complete immunoassay reagent kits designed to support research and IVD assay development workflows with readily available materials, intended to accelerate development timelines for diagnostic assay developers.

Companies that use KPL

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

KPL technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature9 records

KPL partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

KPL competitors and assessment

Company assessment

Broad incumbents

  • Roche Diagnostics: Roche Diagnostics is a global IVD leader across molecular, immunoassay, and clinical chemistry. It represents both an overlapping reference material/QC capability and a key end-customer segment that purchases OEM reference standards for its own assay development.
  • Thermo Fisher Scientific: Thermo Fisher offers a broad portfolio of diagnostic reference materials, immunoassay reagents, and clinical QC tools through its Specialty Diagnostics and Life Sciences Solutions segments. It overlaps with SeraCare/KPL across antibodies, controls, and NGS reference standards but at much larger scale and broader scope.
  • QuidelOrtho: QuidelOrtho is a major IVD manufacturer with extensive immunoassay and infectious disease testing capabilities. It is a partial peer through its proprietary assay development but also a customer of reference materials like those SeraCare/KPL provides.

Direct peers

  • ZeptoMetrix: ZeptoMetrix (part of Antylia Scientific) specializes in infectious disease reference materials, seroconversion panels, and viral antigens — directly overlapping with SeraCare's AccuVert, AccuSet, and Virusys product lines for IVD assay developers.
  • Bio-Rad Laboratories: Bio-Rad is one of the largest manufacturers of IVD quality controls, reference materials, and specialty diagnostics reagents. It directly competes with SeraCare/KPL across molecular QC, serology controls, and immunoassay reagents, serving the same clinical lab and IVD developer customers.
  • Streck: Streck develops clinical lab quality controls, stabilization products, and reference materials for hematology, molecular, and infectious disease testing. It competes head-to-head with SeraCare's ACCURUN and panel products in clinical laboratory QC workflows.
  • Surmodics: Surmodics' Diagnostics division provides IVD reagents, antigens, antibodies, and OEM assay components to diagnostic manufacturers — a directly comparable offering to KPL's antibodies, conjugates, and immunoassay reagent kits.

Others

  • SeraCare Life Sciences (parent brand): SeraCare is the umbrella commercial brand under which KPL operates; included as a peer to clarify the parent-brand relationship rather than as a true external competitor (it is the same legal entity, LGC Clinical Diagnostics, Inc.).

Emerging players

  • ATCC: ATCC provides biological reference materials, cell lines, and microbial standards used in assay development and QC. It overlaps with SeraCare's disease state specimens and recombinant virus materials for select IVD and research applications.
  • Maine Biotechnology Services: Maine Biotechnology Services specializes in custom antibody development and immunoassay reagents for IVD and research applications, overlapping with KPL's antibody and conjugate offerings for smaller-volume or custom OEM needs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

KPL social profiles

Digital presence

KPL financial estimates

Financial estimate

Revenue estimate

Valuation estimate

KPL leadership team

Management profile

Number of profiles

KPL subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

KPL funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

KPL M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KPL

What does KPL do?

KPL (Kirkegaard & Perry Laboratories) is a product line and sub-brand of SeraCare Life Sciences (LGC Clinical Diagnostics) that manufactures and sells ready-to-use antibodies, conjugates, and immunoassay reagent kits. These products are designed to accelerate research workflows and in vitro diagnostic (IVD) assay development for clinical laboratories, IVD manufacturers, and assay developers.

Is KPL a public or private company?

KPL is a private company. It is classified as corporate owned and is currently operating.

When was KPL founded?

KPL was founded in -1. It employs 11 to 50 people.

Where is KPL based?

KPL is headquartered in Milford, United States, in the North America region.

How does KPL make money?

Three revenue lines are on record. KPL Immunoassay Products are the primary driver. The others are reference Materials & Controls and custom Services.

Who are KPL's main competitors?

Broad incumbents on record are Roche Diagnostics, Thermo Fisher Scientific and QuidelOrtho. Direct peers are ZeptoMetrix, Bio-Rad Laboratories, Streck and Surmodics. SeraCare Life Sciences (parent brand) is listed as an others. Emerging players are ATCC and Maine Biotechnology Services.

Does KPL have an API?

No public API is recorded for KPL.

What industry is KPL in?

KPL's product category is Diagnostic Reagents. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales